Method for determining proliferation and differentiation regulation of quail embryo leg muscle myoblast based on m6A methylation
Through MeRIP-seq omic analysis, differentially expressed genes of m6A methylation in quail embryonic leg muscles were identified, which solved the technical problems of proliferation and differentiation regulation of myoblasts in quail embryonic leg muscles, and provided data support related to quail cultivation , m6A modification was found to play a key role in the proliferation and differentiation of quail leg muscle cells.
Patent Information
- Application Number
- CN202411489433.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-24
- Publication Date
- 2024-12-03
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing technology has failed to effectively study and solve the regulation of m6A methylation during the proliferation and differentiation of myoblasts in the quail embryonic leg, and there is a lack of relevant reports and technical support.
Through MeRIP-seq omic analysis, total RNA of leg muscles on day 8 and day 14 of quail embryo phase was extracted, and strand-specific libraries were enriched using m6A-specific antibodies, and differential methylation was identified using sequencing and comparative analysis. RNA and GO and KEGG enrichment analysis were performed to identify m6A methylated highly expressed genes involved in myoblast proliferation and differentiation.
It was found that m6A modification is common in the development of quail leg muscles and is differentially expressed in different embryo ages, and genes related to calcium ion signaling pathways and cardiomyocyte adrenergic signaling pathways were identified, such as CACNA1C, FLT1, FLT4, ERBB2, IGF1R provides data support and technical support for quail cultivation.
Smart Images

Figure CN119061164A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of molecular detection, and in particular to a method for measuring proliferation and differentiation regulation of quail embryonic leg muscle myoblasts based on m6A methylation. Background Art
[0002] N6-methyladenosine (m 6 A) The modification occurs at the adenosine N6 site of mRNA and is a post-transcriptional modification process that regulates gene expression in mammals. 6 The regulation of A is achieved through a dynamic and reversible regulatory network composed of methyltransferase complexes, demethylases, and methylation reader proteins. The main function of methyltransferase is to catalyze the m 6 A modification, mainly composed of methyltransferase-like 3 / 14, zinc finger CCCH type 13 and Wilms tumor 1 associated protein (WTAP) and other proteins. 6 A modified base demethylation is mainly composed of proteins such as fat mass and obesity-associated protein (FTO) and AlKB homolog 5 (ALKHB5). The main function of the reader protein is to recognize m 6 A modification occurs at the base, thereby activating the downstream regulatory pathway. Reading proteins are mainly composed of YTH domain family members YTH domain family 1 / 2 / 3 (YTHDF1 / 2 / 3), YTH domain 1 / 2 (YTHDC1 / 2), insulin-like growth factor 2 mRNA binding protein (IGF2BPs) and several heterogeneous nuclear ribonucleoproteins (hnRNPs). More and more studies have shown that m 6 Effects of A on the proliferation of poultry myoblasts. However, there are no reports on the proliferation and differentiation of leg muscle myoblasts of quail embryos.
[0003] Based on previous studies, the present invention used MeRIP-seq omics analysis on leg muscles of quail embryonic days 8 and 14 to find the m 6 A regulates related differentially expressed genes. 6 A modification is commonly found in the development of leg muscles in quail embryos, and there are obvious differences in expression in different embryonic ages of leg muscle differentiation. 6 A modification plays a key role in the proliferation and differentiation of quail leg muscle cells, providing data support for the guidance of subsequent breeding of quail. Summary of the invention
[0004] The purpose of the present invention is to provide a method for determining the proliferation and differentiation regulation of quail embryonic leg muscle myoblasts based on m6A methylation to solve the problems existing in the above-mentioned prior art. 6A modification is commonly found in the development of leg muscles in quail embryos, and there are obvious differences in expression in different embryonic ages of leg muscle differentiation. 6 A modification plays a key role in the proliferation and differentiation of quail leg muscle cells. The present invention can provide data support and technical support for quail breeding.
[0005] To achieve the above object, the present invention provides the following solutions:
[0006] The present invention provides a method based on m 6 A method for determining the proliferation and differentiation regulation of quail embryo leg muscle myoblasts by methylation, comprising the following steps:
[0007] The leg muscles of quail embryos at embryonic days 8 and 14 were taken to extract total RNA to obtain RNA samples;
[0008] The RNA sample was divided into two parts, one of which was 6 A was enriched with specific antibodies, and the other was left untreated as a control, and strand-specific libraries were constructed for the two RNAs;
[0009] The library was sequenced, aligned and peak scanned to obtain m 6 Peak A;
[0010] For m 6 Peak A was enriched and analyzed to obtain differentially methylated RNA.
[0011] Furthermore, before dividing the RNA sample into two parts, the method also includes a step of performing quality detection on the RNA sample.
[0012] Furthermore, when the RNA sample peak graph has a flat baseline, RIN>7, and the ratio of the peak height of 28s rRNA to the peak height of 18s rRNA is 1:2, the quality test is qualified.
[0013] Furthermore, the method also includes the step of performing GO and KEGG enrichment analysis on the differentially methylated RNA to identify the differentially methylated RNA.
[0014] Furthermore, the biological processes obtained by the GO enrichment analysis of differentially methylated RNA include cellular processes, single biological processes and metabolic processes.
[0015] Furthermore, the signal pathways obtained by the KEGG enrichment analysis of differentially methylated RNA include a calcium ion signaling pathway and an adrenergic signaling pathway in cardiomyocytes.
[0016] Furthermore, m 6 A. The highly expressed genes with methylation were CACNA1C, FLT1, FLT4, ERBB2 and IGF1R.
[0017] The present invention also provides application of the method in identifying differentially methylated RNA regulating proliferation and differentiation of quail embryo leg muscle myoblasts.
[0018] The invention also provides application of the method in regulating the development of quail leg muscles.
[0019] The present invention discloses the following technical effects:
[0020] The present invention discloses a method based on m 6 A method for determining the regulation of proliferation and differentiation of quail embryonic leg muscle myoblasts by methylation. Quail embryonic day 8 (E8) and day 14 (E14) leg muscles were selected for MeRIP-seq transcriptional analysis. 6 A modification was identified and 28919 m 6 Peak A, E14 has 22839 m 6 Peak A. Differentially expressed m 6 Peak A was mainly enriched in items related to material and energy metabolism. KEGG enrichment analysis showed that quail leg muscle proliferation and differentiation were closely related to the calcium ion signaling pathway and the adrenergic signaling pathway in cardiomyocytes.
[0021] Furthermore, the present application found through constructing a protein network interaction diagram that m 6 The genes with significant methylation differences and high expression levels include CACNA1C, FLT1, FLT4, ERBB2, and IGF1R. These genes are respectively related to calcium ion channels, vascular endothelial growth factor receptor coding, protein coding, and are involved in cell growth and control as well as cell proliferation, differentiation, maturation, and apoptosis mechanisms. 6 A methylation is closely related to the growth and development of muscle cells.
[0022] In summary, the present invention finds that m 6 A modification is commonly found in the development of leg muscles in quail embryos, and there are obvious differences in expression in different embryonic ages of leg muscle differentiation. 6 A modification plays a key role in the proliferation and differentiation of quail leg muscle cells. The present invention can provide data support and technical support for quail breeding. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0024] Figure 1Peak diagram for RNA purity and concentration detection;
[0025] Figure 2 The peak detection diagrams of each group; A: Statistical diagram of the number of peaks on the gene; B: Distribution diagram of the peak relative to the gene position;
[0026] Figure 3 Peak-related gene enrichment analysis diagram; A: GO enrichment classification bar chart of E8 sample; B: GO enrichment classification bar chart of E14 sample;
[0027] Figure 4 KEGG enrichment bubble diagram of E8 sample (A) and E14 sample (B);
[0028] Figure 5 The motif analysis results for E8 samples (first and second rows) and E14 samples (third row);
[0029] Figure 6 Peak analysis diagram between groups; A: reads correlation heat map; B: peak volcano map of differences between groups;
[0030] Figure 7 It is the GO enrichment classification bar chart of peak-related genes with differences between groups;
[0031] Figure 8 It is the functional analysis enrichment diagram of the peak-related genes with differences between groups; the upper figure is the KEGG enrichment bubble diagram; the lower figure is the protein network interaction diagram. DETAILED DESCRIPTION
[0032] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0033] It should be understood that the terms described in the present invention are only for describing a particular embodiment and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.
[0034] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.
[0035] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.
[0036] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.
[0037] Example 1
[0038] Quail eggs on embryonic day 8 (E8) and day 14 (E14) were randomly selected, and the embryos were carefully removed under a sterile environment after surface disinfection and cleaning. Leg muscle samples were collected and quickly frozen in liquid nitrogen and stored at -80°C for MeRIP-seq analysis.
[0039] Total RNA was extracted from the leg muscle of male quail embryos using Trizol reagent, and the concentration and integrity of RNA samples were tested using NanoDropND-1000. Sample quality was qualified (using Agilent 2100 peak map ( Figure 1 ) Judgment: baseline is flat; RIN value>7; there are generally 4 peaks, the 5s rRNA peak is generally not obvious, and the peak height of 28s rRNA is generally twice that of 18s rRNA peak), then the library is constructed.
[0040] RNA fragmentation: RNA samples were fragmented into fragments of approximately 100 nt in length using the NEB E7490L kit (purchased from New England Biolabs);
[0041] The RNA was divided into two parts, one of which was used for m 6 A specific antibody enrichment; capture m 6 After the modified RNA is purified by A, the antibody is eluted with magnetic beads to reduce the background noise of nonspecific binding; the other is used as an input control (i.e., no IP experiment is performed) to directly construct a transcriptome sequencing library to eliminate the background in the process of capturing methylated fragments.
[0042] Strand-specific libraries were constructed for the two RNAs: the mRNA was separated and interrupted, the cDNA double strands were synthesized and purified, the cDNA ends were repaired, polyA tails and adapters were added to the obtained RNA, the obtained fragments were then screened, and finally the PCR library was enriched and purified.
[0043] After the library construction is completed, the library is quality tested. The qualified libraries are sequenced on the machine.
[0044] The raw data were filtered and quality controlled using fastp to remove reads containing adapters, reads with an N ratio greater than 10%, reads that were all A bases, and low-quality reads (the number of bases with a quality value of Q≤20 accounted for more than 50% of the entire read) to obtain clean reads. E8 obtained 64824244 to 85091750 clean reads; E14 obtained 71520598 to 102054218 clean reads (Table 1).
[0045] Table 1 Reads filtering information statistics
[0046]
[0047]
[0048] The comparison results between the effective data and the reference gene showed that the base Q20 accounted for more than 97.70.31% of the filtered samples; the GC content accounted for 52.66% to 53.89 (Table 2). In summary, the sequencing data obtained by E8 and E14 had a balanced base composition and high base quality, which met the analysis requirements.
[0049] Table 2 Base information statistics
[0050]
[0051]
[0052] The short reads alignment tool bowtie2 was used to align high-quality clean reads to the quail ribosome database, and the reads aligned to the ribosomal RNA were removed. The HISAT2 software was used to perform an alignment analysis based on the reference genome, and the reads were aligned as completely as possible, including alternative splicing and polyA tails, as well as reads spanning alternative splicing sites or polyA tail edges. The number of reads uniquely aligned to the reference genome and the proportion of valid reads were 60.04% to 72.15%; the number of reads that could be located on the genome and the proportion of valid reads were 62.97% to 73.81% (Table 3).
[0053] Table 3 Comparison reference statistics
[0054]
[0055]
[0056] The R package exomePeak2 was used to perform peak calling on a genome-wide scale in groups, with a default threshold of p value < 1e -5 . And for m 6 The peak position information on the genome and the peak region sequence information were analyzed to screen out peak-related genes and perform gene function enrichment analysis. 28919 and 22839 peaks were found in E8 and E14, respectively (Table 4). The proportion of genes containing a single peak in E8 was lower than that in E14, at 35.35% and 42.42%, respectively. The proportion of genes containing two peaks in E8 and E14 was similar, at 28.28% and 27.66%, respectively ( Figure 2 The number and percentage of peaks in the 5'UTR, CDS, and 3'UTR of the coding gene were calculated. The results showed that the E8 and E14 peaks were mainly distributed in the regions before and after the start codon and the stop codon (the CDS region near the start codon, the CDS region near the stop codon, and the 3'UTR region) ( Figure 2 (middle B).
[0057] Table 4 Statistics of peak numbers in each group
[0058]
[0059] Peak-related genes were mapped to each term in the GO database (http: / / www.geneontology.org / ), and the number of peak-related genes for each term was calculated. Then, the hypergeometric test was applied to find the GO terms that were significantly enriched in the peak-related genes compared with the background. The results showed that the GO terms with the most genes distributed in E8 in biological processes were cellular process (GO:0009987) and single organism process (GO:0044699), with 10056 and 9460 genes, respectively. The GO terms with the most genes distributed in cellular components were cell (GO:0005623) and cell part (GO:0044464), with 9806 and 9803 genes, respectively. The GO terms with the most genes distributed in molecular functions were binding (GO:0005488) and catalytic activity (GO:0003824), with 8759 and 4978 genes, respectively. Figure 3 The GO terms with the most genes in biological processes of E14 are cellular process (GO:0009987) and single-organism process (GO:0044699), with 8906 and 8342 genes, respectively. The GO terms with the most genes in cellular components are cell (GO:0005623) and cell part (GO:0044464), with 8694 and 8692 genes, respectively. The GO terms with the most genes in molecular function are binding (GO:0005488) and catalytic activity (GO:0003824), with 7786 and 4480 genes, respectively. Figure 3 Middle B) Items enriched in E8 and E14 play key roles in myoblast growth and development.
[0060] Pathway significant enrichment can determine the most important biochemical metabolic pathways and signal transduction pathways involved in peak-related genes. KEGG enrichment analysis found that the secondary pathways with significant expression and more genes in E8 were ribosome pathway (Ribosome, ko03010), spliceosome pathway (Spliceosome, ko03040), animal autophagy pathway (Autophagy–animal, ko04140), actin cytoskeleton regulation pathway (Regulation of actin cytoskeleton, ko04810), ubiquitin mediated proteolysis pathway (Ubiquitin mediated proteolysis, ko04120), endocytosis pathway (Endocytosis, ko04144), and wnt signaling pathway (Wnt signaling pathway, ko04310), which are related to the growth and development of myoblasts ( Figure 4 Middle A). The secondary pathways with significant expression and high gene distribution in E14 were ribosome pathway (Ribosome, ko03010), autophagy pathway (Autophagy–animal, ko04140), spliceosome pathway (Spliceosome, ko03040), ubiquitin mediated proteolysis pathway (Ubiquitin mediated proteolysis, ko04120), gap junction pathway (Gap junction, ko04540), with 72 genes; adrenergic signaling in cardiomyocytes (Adrenergic signaling in cardiomyocytes, ko04261), mRNA surveillance pathway (mRNA surveillance pathway, ko03015) ( Figure 4 (B) Peak-related genes in E8 and E14 participate in pathways that play important roles in protein construction and abundance, signal transduction, cell cycle regulation, cell proliferation and differentiation.
[0061] The frequency (RRACH, DRACH) distribution of specific motifs in all peaks of all samples was counted, and an average base frequency matrix was constructed for each motif for motif analysis. Visual analysis of significant motifs in the peaks of sample E8 showed that the number of input sequences with the motif with the highest probability of specific motif frequency RRACH accounted for the largest proportion, accounting for 62.39%, and the number of input sequences with the motif with the highest probability of specific motif frequency RRACH in E14 accounted for 47.62% (Table 5, Table 6, Figure 5 ).
[0062] Table 5E8 Sample motif analysis
[0063] P-value Target / % background / % 1e-1241 42.92% 20.73% 1e-1097 45.29% 23.85% 1e-341 26.41% 16.13% 1e-304 52.90% 40.83% 1e-62 62.39% 57.02%
[0064] Table 6E14 Sample motif analysis
[0065] P-value Target / % background / % 1e-1040 55.96% 31.22% 1e-554 65.08% 46.72% 1e-239 26.17% 16.47% 1e-230 47.62% 35.96%
[0066] DiffBind software was used to merge the peaks between groups to obtain the union of the peaks between each treatment group, and exomePeak2 was used to obtain the expression level of the merged peaks in each sample. A total of 32,686 merged peaks were obtained (Table 7). The correlation analysis of the unique aligned reads found that the Pearson correlation coefficient between samples was lower than that of the remaining samples, which was greater than 0.9, indicating that the similarity of RNA methylation patterns between samples was extremely high ( Figure 6 The relative methylation rate of each peak of E8 and E14 was calculated and each peak was compared and analyzed for differences, and 379 up-regulated peaks and 1561 down-regulated peaks were screened out (P<0.05 and |log2FC|>1) (Table 8). The volcano plot better illustrates the significant differentially expressed peaks ( Figure 6 (middle B).
[0067] Table 7 Merged peaks
[0068]
[0069] Table 8 Statistics of peak numbers between groups
[0070] Increase Downward adjustment total E8-vs-E14 379 1561 1940
[0071] Compared with the background, the GO entries of differential peak-related genes are significantly enriched. In biological processes, the GO entries with the most gene distribution are cellular process (Cellular process, GO: 0009987), single-organism process (Single-organism process, GO: 0044699) and metabolic process (Metabolic process, GO: 0008152), with 1493, 1399 and 1205 genes respectively. In cell components, the GO entries with the most gene distribution are cell (Cell, GO: 0005623), cell part (Cell part, GO: 0044464) and organelle (Organelle, GO: 0043226), with 1455, 1454 and 1212 genes respectively. In molecular function, the GO entries with the most gene distribution are binding (Binding, GO: 0005488) and catalytic activity (Catalytic activity, GO: 0003824), with 1347 and 750 genes respectively. Figure 7 ).
[0072] KEGG enrichment analysis found that the secondary pathways with significant and high gene distribution included calcium signaling pathway (ko04020) and adrenergic signaling in cardiomyocytes (ko04261). These pathways are closely related to many physiological processes of cells, such as cell proliferation, differentiation, apoptosis, metabolism, and movement ( Figure 8 (top middle picture).
[0073] The genes in several KEGG pathways with the highest significance were selected to construct a protein network interaction diagram. The results showed that the hub genes were CACNA1C, FLT1, FLT4, ERBB2, and IGF1R. These genes are respectively related to calcium ion channels, vascular endothelial growth factor receptor coding, protein coding, and are involved in cell growth and control as well as cell proliferation, differentiation, maturation, and apoptosis mechanisms ( Figure 8 From this we can see that m 6 A highly expressed gene with significant methylation difference is closely related to the growth and development of muscle cells.
[0074] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.
Claims
1. Based on m 6 A method for determining the proliferation and differentiation regulation of quail embryo leg muscle myoblasts by A methylation, characterized in that The following steps are involved: The leg muscles of quail embryos at embryonic days 8 and 14 were taken to extract total RNA to obtain RNA samples; The RNA sample was divided into two parts, one of which was 6 A was enriched with specific antibodies, and the other was left untreated as a control, and strand-specific libraries were constructed for the two RNAs; The library was sequenced, aligned and peak scanned to obtain m 6 Peak A; For m 6 Peak A was enriched and analyzed to obtain differentially methylated RNA.
2. The method according to claim 1, characterized in that Before dividing the RNA sample into two parts, the method further includes a step of performing a quality test on the RNA sample.
3. The method according to claim 2, characterized in that When the baseline of the RNA sample peak graph is flat, RIN>7, and the ratio of the peak height of 28s rRNA to the peak height of 18s rRNA is 1:2, the quality test is qualified.
4. The method according to claim 1, characterized in that It also includes GO enrichment analysis and KEGG enrichment analysis on differentially methylated RNA to identify the steps of differentially methylated RNA.
5. The method according to claim 4, characterized in that The biological processes obtained by the GO enrichment analysis of differentially methylated RNA include cellular processes, single biological processes and metabolic processes.
6. The method according to claim 4, characterized in that The signal pathways obtained by the KEGG enrichment analysis of differentially methylated RNA include a calcium ion signaling pathway and an adrenergic signaling pathway in cardiomyocytes.
7. The method according to claim 1, characterized in that m involved in the regulation of proliferation and differentiation of myoblasts in quail embryonic leg muscles 6 A. The highly expressed genes with methylation were CACNA1C, FLT1, FLT4, ERBB2 and IGF1R.
8. Use of the method according to any one of claims 1 to 6 in identifying differentially methylated RNAs that regulate proliferation and differentiation of leg muscle myoblasts in quail embryos.
9. Use of the method according to any one of claims 1 to 6 in regulating the development of quail leg muscles.
Citation Information
Patent Citations
Method for researching duck embryonic phase skeletal muscle development influence factors based on m6A methylation
CN117625800A
Method for determining proliferation regulation of goose embryo pectoralis myoblast by m6A
CN117660613A
